AcAdeMiC: Acting With Acceptance, Mindfulness and Compassion to Overcome Test/Exam Anxiety (AcAdeMiC)

AcAdeMiC: Acting With Acceptance, Mindfulness and Compassion to Overcome Test/Exam Anxiety - An ICT-based Psychotherapeutic Intervention for Adolescents

Test Anxiety is a highly prevalent and impairing condition in adolescents (i.e., 9th to 12th grade students), significantly impacting on their mental health and well-being. Among Portuguese university students, test anxiety is the primary reason for seeking specialized psychological support, suggesting the importance of early intervention.

Test anxiety associates to low self-compassion, acceptance and mindfulness, which have been increasingly acknowledged in literature as important processes to cultivate towards human experience and suffering, within intervention programs, particularly in adolescence, and in anxiety and fear of failure in academic settings.

These processes are covered and enhanced within comprehensive models and evidence-based therapies that adopt an integrative, contextual and biopsychosocial approach, such as Acceptance and Commitment Therapy (ACT), and Mindfulness-Based Cognitive Therapy (MBCT), as well as an evolutionary approach, such as Compassion Focused Therapy (CFT). These approaches focus on receiving internal events (e.g., thoughts, emotions, memories) in an accepting and compassionate way, as part of human experience, without changing them, while developing a sense of vitality, well-being and commitment to valued ends in life, instead of focusing solely or mainly on symptom reduction (although it is usually a consequent outcome).

However, there are no empirically validated therapeutic programs for adolescents with test anxiety promoting these processes combined.

ICT-based interventions are accessible, convenient, cost-effective and have been proved effective in reducing anxiety disorders' symptomatology. Even though there are some empirically validated online interventions for test anxiety in adolescents, having shown promising results, these were mainly self-help/module-based programs, without a clinician facilitating the intervention.

This project aims to develop and implement a 12-week ICT-based targeted, facilitated and manualized individual intervention for adolescent students, developing compassion, acceptance and mindfulness, in order to help improve test anxiety's regulation (and consequently symptom reduction), as well as increase general and school-related well-being, while promoting valued life action.

Study Overview

• Status: Completed
• Conditions: Test Anxiety; Adolescents
• Intervention / Treatment: Behavioral: Intervention program for test anxiety

Detailed Description

All ethical and deontological requirements are guarenteed in this study.

A sample of adolescent students (from 9th to 12th grade) is being online-recruited, through social media and contacts with Executive Boards of Portuguese secondary schools, private practices and study centers, advertising the study.

Parents/legal guardians are encouraged to contact the team. From this approach, parents/legal guardians and respective adolescents who demonstrate interest are explained the aims and procedures of the study and asked to sign a written consent form.

Adolescents are then assessed for eligibility through a test anxiety self-report measure and a clinical interview.

Eligible participants will be randomly assigned to either an experimental group, who will reveive the intervention (facilitated by licenced psychotherapists with training in contextual therapies and are familiar with the intervention protocol), or a waiting-list control group, who will have access to the intervention after the six-month follow-up assessment.

Both groups will complete a protocol with self-report measures, assessing psychopathology indicators, emotion regulation processes, and general and school-related well-being, in four different moments: at baseline (M0), immediatly after the intervention (M1), three months (M2) and six months (M3) after the intervention.

• Study Type: Interventional
• Enrollment (Actual): 64
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Portugal
  • Coimbra, Portugal, 3000-115
    • University of Coimbra

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 13 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• provision of written informed consent by participants and their legal guardians;
• presence of high levels of test anxiety, confirmed through self-report assessment and clinical interview;
• educational level from 9th to 12th grade;
• absence of Neurodevelopmental Disorders, except Specific Learning Disorders of mild severity;
• absence of any degree of cognitive decline or impairment;
• absence of any severe Depressive Disorder;
• absence of any other severe psychiatric condition (e.g., Obsessive-Compulsive Disorder, Bipolar Disorder, Psychotic Disorders);
• not being under treatment for a psychiatric condition.

Exclusion Criteria:

• no provision of written informed consent by participants and their legal guardians;
• absence of high levels of test anxiety, confirmed through self-report assessment;
• educational level below 9th and above 12th grade;
• presence of Neurodevelopmental Disorders, except Specific Learning Disorders of mild severity;
• presence of any degree of cognitive decline or impairment;
• presence of any severe Depressive Disorder;
• presence of any other severe psychiatric condition (e.g., Obsessive-Compulsive Disorder, Bipolar Disorder, Psychotic Disorders);
• being under treatment for a psychiatric condition.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention program for test anxiety; 12 weekly ICT-delivered individual sessions.	Behavioral: Intervention program for test anxiety; 12-week ICT-based manualized, targeted and facilitated individual intervention for adolescent students, that aims to promote compassion, acceptance and mindfulness, in order to help improve test anxiety's regulation (and consequently symptom reduction), as well as increase general and school-related well-being, while promoting valued life action.; Other Names: AcAdeMiC: Acting With Acceptance, Mindfulness and Compassion to Overcome Test/Exam Anxiety
No Intervention: Control; Waiting list that will have access to the intervention program after the 6-month follow-up assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Test Anxiety	Reactions to Tests for Adolescents (RT-A). Participants rate the items on a Likert scale from 1 to 4. Lower scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
General well-being	Mental Health Continuum - Short Form - for Youth (MHC-SF). Participants rate the items on a Likert scale from 0 to 5. Higher scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
School-related well-being	School-related Well-Being Scale (SWBS). Participants rate the items on a Likert scale from 1 to 5. Higher scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
Psychological flexibility in test situations	Test Anxiety Acceptance and Action Questionnaire for Adolescents (TA-AAQ-A). Participants rate the items on a Likert scale from 1 to 7. Higher scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
General psychological flexibility	Avoidance and Fusion Questionnaire for Youth (AFQ-Y). Participants rate the items on a Likert scale from 0 to 4. Lower scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
Mindfulness	Child and Adolescent Mindfulness Measure (CAMM). Participants rate the items on a Likert scale from 0 to 4. Higher scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
Self-compassion	Self-Compassion Scale (SCS-A). Participants rate the items on a Likert scale from 1 to 5. Higher scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression, anxiety and stress	Depression Anxiety and Stress Scales (DASS-21). Participants rate the items on a Likert scale from 0 to 3. Lower scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
Self-criticism	Forms of Self-Criticizing/attacking and self-Reassuring Scale (FSCRS-A). Participants rate the items on a Likert scale from 0 to 4. Lower scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]
Shame	External and Internal Shame Scale for adolescents (EISS-A). Participants rate the items on a Likert scale from 0 to 4. Lower scores indicate a better outcome	6 months [From Baseline to 6 months follow-up]

Collaborators and Investigators

• Sponsor: University of Coimbra
• Collaborators: Fundação para a Ciência e a Tecnologia; CINEICC - Center for Research in Neuropsychology and Cognitive Behavioral Intervention
• Investigators: Principal Investigator: Cláudia P. Pires, M.Sc., University of Coimbra

Study record dates

Study Major Dates

• Study Start (Actual): March 15, 2021
• Primary Completion (Actual): July 31, 2022
• Study Completion (Actual): July 31, 2022

Study Registration Dates

• First Submitted: April 22, 2021
• First Submitted That Met QC Criteria: April 22, 2021
• First Posted (Actual): April 27, 2021

Study Record Updates

• Last Update Posted (Actual): December 2, 2022
• Last Update Submitted That Met QC Criteria: December 1, 2022
• Last Verified: December 1, 2022

More Information

Terms related to this study

• Keywords: mindfulness; adolescents; compassion; test anxiety; acceptance
• Additional Relevant MeSH Terms: Mental Disorders; Anxiety Disorders
• Other Study ID Numbers: SFRH/BD/143520/2019

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No